Worth reading
56In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Announced details
Kirei Pass Connect byGMOWebORCAキレイパス byGMOくまポン byGMO
Applicable field (uses covered by this announcement)
自由診療・美容クリニック、保険診療、一般皮膚科、医療機関の受付・カルテ・レセプト業務
Launch date2025年12月22日（提供開始済み）
Relationship between the counterparty and the company
GMO Media,Inc.6180
Relationship with the Company
GMOビューティーの『キレイパスコネクト byGMO』と、日本医師会ORCA管理機構提供の『WebORCA』を連携。資本関係・人的関係はNot disclosed。
Counterparty日本医師会ORCA管理機構
クラウド型日医標準レセプトソフト『WebORCA』を提供。WebORCAは日本医師会が主導する医事会計ソフト『ORCA』のクラウド版。その他の所在地・代表者・資本金・設立年はNot disclosed。
Location (as indicated in this announcement)
Cerulean Tower, 26-1 Sakuragaoka-cho, Shibuya-ku, Tokyo (GMO Beauty株式会社)
Impact on Business Performance
本件に関して業績に与える影響は軽微
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Kirei Pass Connect byGMO, WebORCA, キレイパス byGMO, くまポン byGMO |
| Counterparty | 日本医師会ORCA管理機構 |
| Counterparty overview | クラウド型日医標準レセプトソフト『WebORCA』を提供。WebORCAは日本医師会が主導する医事会計ソフト『ORCA』のクラウド版。その他の所在地・代表者・資本金・設立年はNot disclosed。 |
| Relationship with the Company | GMOビューティーの『キレイパスコネクト byGMO』と、日本医師会ORCA管理機構提供の『WebORCA』を連携。資本関係・人的関係はNot disclosed。 |
| Launch date | 2025年12月22日（提供開始済み） |
| Applicable area | 自由診療・美容クリニック、保険診療、一般皮膚科、医療機関の受付・カルテ・レセプト業務 |
| Location | Cerulean Tower, 26-1 Sakuragaoka-cho, Shibuya-ku, Tokyo (GMO Beauty株式会社) |
| Impact on Business Performance | 本件に関して業績に与える影響は軽微 |
Items this document does not state (10)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historySource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.保険診療と自由診療を併用するクリニックで生じていた患者情報の二重入力、システム切り替え、手入力による転記ミスなどの課題を解決し、クリニックのDXを推進するため。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.